Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Microbot Medical Inc. Director's Dealing 2010

Mar 12, 2010

33819_dirs_2010-03-12_bc7482dc-0a72-47e4-b54b-5e40af3e5d18.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2010-03-10

Reporting Person: MCGLYNN MARTIN M (Director, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-03-10 Common Stock F 50435 $1.22 Disposed 459232 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 33892 Indirect

Footnotes

F1: Includes (1) 234,667 restricted stock units, with 1/4 of those vesting on each of the four anniversaries following the grant date and (2) 137,500 restricted stock units, vesting on March 10, 2011.

F2: Shares held in 401(k) account, in accordance with issuer's employer-match policies.